Association of time in range with hemoglobin A1c, glycated albumin and 1,5-anhydro-d-glucitol

被引:21
|
作者
Ohigashi, Mana [1 ]
Osugi, Keiko [1 ]
Kusunoki, Yoshiki [1 ]
Washio, Kahori [1 ]
Matsutani, Satoshi [1 ]
Tsunoda, Taku [1 ]
Matsuo, Toshihiro [1 ]
Konishi, Kosuke [1 ]
Katsuno, Tomoyuki [2 ]
Namba, Mitsuyoshi [3 ]
Koyama, Hidenori [1 ]
机构
[1] Hyogo Coll Med, Dept Diabet Endocrinol & Clin Immunol, Nishinomiya, Hyogo, Japan
[2] Hyogo Univ Hlth Sci, Sch Rehabil, Dept Occupat Therapy, Kobe, Hyogo, Japan
[3] Takarazuka City Hosp, Dept Diabet Mellitus, Takarazuka, Hyogo, Japan
关键词
Continuous glucose monitoring; Hemoglobin A1c; Time in range; BLOOD-GLUCOSE; TYPE-1; 1,5-ANHYDROGLUCITOL; INDICATOR; ANEMIA;
D O I
10.1111/jdi.13437
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims/Introduction Hemoglobin A1c (HbA1c), glycated albumin (GA) and 1,5-anhydro-d-glucitol (1,5-AG) are used as indicators of glycemic control, whereas continuous glucose monitoring (CGM) is used to assess daily glucose profiles. The aim of this study was to investigate the relationships between CGM metrics, such as time in range (TIR), and glycemic control indicators. Materials and Methods We carried out retrospective CGM and blood tests on 189 outpatients with impaired glucose tolerance (n = 22), type 1 diabetes mellitus (n = 67) or type 2 diabetes mellitus (n = 100). Results In type 1 diabetes mellitus and type 2 diabetes mellitus patients, HbA1c and GA were negatively correlated with TIR, whereas 1,5-AG was positively correlated with TIR. In type 1 diabetes mellitus patients, a TIR of 70% corresponded to HbA1c, GA and 1,5-AG of 6.9% (95% confidence interval [CI] 6.5-7.2%), 20.3% (95% CI 19.0-21.7%) and 6.0 mu g/mL (95% CI 5.1-6.9 mu g/mL), respectively. In type 2 diabetes mellitus patients, a TIR of 70% corresponded to HbA1c, GA and 1,5-AG of 7.1% (95% CI 7.0-7.3%), 19.3% (95% CI 18.7-19.9%) and 10.0 mu g/mL (95% CI 9.0-11.0 mu g/mL), respectively. TIR values corresponding to HbA1c levels of 7.0% were 56.1% (95% CI 52.3-59.8%) and 74.2% (95% CI 71.3-77.2%) in type 1 diabetes mellitus and type 2 diabetes mellitus patients, respectively. Conclusions The results of this study showed that the estimated HbA1c corresponding to a TIR of 70% was approximately 7.0% for both type 1 diabetes mellitus and type 2 diabetes mellitus patients, and that the estimated 1,5-AG calculated from the TIR of 70% might be different between type 1 diabetes mellitus and type 2 diabetes mellitus patients.
引用
收藏
页码:940 / 949
页数:10
相关论文
共 50 条
  • [1] Association of Hemoglobin A1c, 1,5-Anhydro-d-Glucitol and Glycated Albumin with Oxidative Stress in Type 2 Diabetes Mellitus Patients: A Cross-Sectional Study
    Kohata, Yo
    Ohara, Makoto
    Nagaike, Hiroe
    Fujikawa, Tomoki
    Osaka, Naoya
    Goto, Satoshi
    Fukase, Ayako
    Kushima, Hideki
    Hiromura, Munenori
    Terasaki, Michishige
    Mori, Yusaku
    Fukui, Tomoyasu
    Ouchi, Motoshi
    Suzuki, Tatsuya
    Hirano, Tsutomu
    Yamagishi, Sho-ichi
    [J]. DIABETES THERAPY, 2020, 11 (03) : 655 - 665
  • [2] Association of Hemoglobin A1c, 1,5-Anhydro-d-Glucitol and Glycated Albumin with Oxidative Stress in Type 2 Diabetes Mellitus Patients: A Cross-Sectional Study
    Yo Kohata
    Makoto Ohara
    Hiroe Nagaike
    Tomoki Fujikawa
    Naoya Osaka
    Satoshi Goto
    Ayako Fukase
    Hideki Kushima
    Munenori Hiromura
    Michishige Terasaki
    Yusaku Mori
    Tomoyasu Fukui
    Motoshi Ouchi
    Tatsuya Suzuki
    Tsutomu Hirano
    Sho-ichi Yamagishi
    [J]. Diabetes Therapy, 2020, 11 : 655 - 665
  • [3] ASSOCIATION OF HEMOGLOBIN A1C, GLYCATED ALBUMIN, AND 1,5-ANHYDRO-D-GLUCITOL ON OXIDATIVE STRESS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: A CROSS-SECTIONAL STUDY
    Ohara, M.
    Nagaike, H.
    Kohata, Y.
    Kushima, H.
    Hiromura, M.
    Terasaki, M.
    Mori, Y.
    Fukui, T.
    Yamagishi, S. -I.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 : A216 - A217
  • [4] SELECTIVE BENZOYLATION OF 1,5-ANHYDRO-D-GLUCITOL
    KONDO, Y
    YABUUCHI, K
    HIRANO, S
    [J]. CARBOHYDRATE RESEARCH, 1980, 82 (02) : 398 - 403
  • [5] Cardiovascular disease and 1,5-anhydro-d-glucitol
    Ikeda, Nobutaka
    Hiroi, Yukio
    [J]. GLOBAL HEALTH & MEDICINE, 2019, 1 (02): : 83 - 87
  • [6] 1,5-anhydro-d-glucitol as a Predictor of Cerebral Infarction in Patients With Glycated Hemoglobin A1c-based Good Diabetes Control
    Shiga, Yuji
    Kanaya, Yuhei
    Takeshima, Shinichi
    Fujikawa, Yasunori
    Takamatsu, Kazuhiro
    Shimoe, Yutaka
    Nishigaki, Masakazu
    Ota, Taisei
    Kuriyama, Masaru
    [J]. STROKE, 2016, 47
  • [7] PARTIAL TOSYLATION OF 1,5-ANHYDRO-D-GLUCITOL
    KONDO, Y
    YABUUCHI, K
    HIRANO, S
    [J]. CANADIAN JOURNAL OF CHEMISTRY-REVUE CANADIENNE DE CHIMIE, 1977, 55 (22): : 2820 - 2824
  • [8] In Vivo Metabolism of 1,5-Anhydro-d-fructose to 1,5-Anhydro-d-glucitol
    Ijiri, Moe
    Yoshinaga, Kazuhiro
    Kawaguchi, Hiroaki
    Miyazaki, Naoto
    Kawaguchi, Maiko
    Fujimoto, Yoshikazu
    Matsuo, Tomohide
    Maruyama, Ikuro
    [J]. IN VIVO, 2023, 37 (03): : 1022 - 1027
  • [9] AROMATIC AND HETEROCYCLIC 1-C-SUBSTITUTED DERIVATIVES OF 1,5-ANHYDRO-D-GLUCITOL
    GRYNKIEWICZ, G
    BEMILLER, JN
    [J]. CARBOHYDRATE RESEARCH, 1984, 131 (02) : 273 - 276
  • [10] Serum 1,5-anhydro-D-glucitol levels in liver cirrhosis
    Yamagishi, S
    Ohta, M
    [J]. ACTA DIABETOLOGICA, 1998, 35 (01) : 65 - 66